Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prolonged Beneficial Effect of Brief Erythropoietin Peptide JM4 Therapy on Chronic Relapsing EAE.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: August 27, 2020
Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy.
Journal: Alzheimer's research & therapy
Published: June 08, 2020
Increased frequency of canine distemper virus-specific antibodies in multiple sclerosis.
Journal: Brain and behavior
Published: March 24, 2020
In vivo Bioluminescence Imaging Used to Monitor Disease Activity and Therapeutic Response in a Mouse Model of Tauopathy.
Journal: Frontiers in aging neuroscience
Published: April 08, 2019
Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 31, 2015
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: August 15, 2015
Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.
Journal: Journal of hematology & oncology
Published: October 25, 2014
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.
Journal: International journal of MS care
Published: October 01, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026